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Abstract
Objectives We designed a prospective study to investigate the
in-vivo relationship between abdominal body composition
and radiation exposure to determine the strongest body com-
position predictor of dose length product (DLP) at CT.
Methods Following institutional review board approval,
quantitative analysis was performed prospectively on 239
consecutive patients who underwent abdominopelvic CT.
DLP, BMI, volumes of abdominal adipose tissue, muscle,
bone and solid organs were recorded.
Results All measured body composition parameters correlat-
ed positively with DLP. Linear regression (R2 = 0.77) revealed
that total adipose volume was the strongest predictor of radi-
ation exposure [B (95% CI) = 0.027(0.024–0.030),
t=23.068, p < 0.001]. Stepwise linear regression using DLP
as the dependent and BMI and total adipose tissue as indepen-
dent variables demonstrated that total adipose tissue is more
predictive of DLP than BMI [B (95% CI) = 16.045 (11.337-
20.752), t=6.681, p < 0.001].
Conclusions The volume of adipose tissue was the strongest
predictor of radiation exposure in our cohort.
Main message
• Individual body composition variables correlate with DLP at
abdominopelvic CT.
• Total abdominal adipose tissue is the strongest predictor of
radiation exposure.
• Muscle volume is also a significant but weaker predictor of
DLP.
Keywords Tomography, X-ray computed . Radiation
dosage . Intra-abdominal fat . Muscle, Skeletal . Bodymass
index
Introduction
At present there is a considerable research and industry drive
to reduce the radiation dose during CT scanning while pre-
serving image quality and diagnostic accuracy. To date, CT
dose reduction technology including automated tube current
modulation and iterative reconstruction have facilitated reduc-
tions in CT dose to levels approximately 70–75% less than
what they were a decade ago. Larger reductions in dose are
conceivable with continued research and development and
more recent advances in CT technology have facilitated sig-
nificant dose reductions without sacrificing image quality
[1–3].
Differences in patient size and body weight challenge the
pathways of CT dose reduction. It is well recognised that
patients with a larger body habitus are exposed to significantly
larger doses of ionising radiation during abdominopelvic CT
when automated tube current modulation (ATCM) is
employed [4–7]. Previous studies have examined the influ-
ence of variables such as body weight [6], body mass index
[4], patient cross-sectional area [5, 7] and patient AP diameter
[8] on imparted dose during abdominopelvic CTwith ATCM.
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However, the abdominal compartment housesmany structures
of varying volume and density, which impact these indices.
These constituents include the solid abdominal organs, soft
tissue structures such as abdominal musculature and adipose
tissue and bony structures such as the lumbar spine and pelvis.
These structures all contribute to patient body weight, body
mass index and cross-sectional area and are therefore also
likely to contribute individually to the imparted dose during
abdominopelvic CT. Although one previous study found
an association between subjectively graded quantities of
abdominal fat and effective dose [9], we found no study
that has investigated the in-vivo relationship between mul-
tiple abdominal body composition variables and radiation
dose during CT with ATCM. The authors believe that fur-
ther investigation of such factors, which may significantly
differ among individuals of similar weight, cross-sectional
area and BMI [10], may guide future methods of dose
optimisation in abdominopelvic CT and may allow radiol-
ogists to refine examination technique and ATCM protocol
particularly in obese patients.
We therefore designed a prospective, cross-sectional study
with the following aims:
(1) To identify the body composition determinants of an
elevated dose length product during abdominopelvic CT.
(2) To determine which of the following parameters is the
strongest predictor of radiation dose at CT:
& Total abdominopelvic adipose tissue volume
& Abdominopelvic muscle volume
& Abdominopelvic bone volume
& Solid organ volumes
Materials and methods
Following institutional review board approval, 239 consecu-
tive patients who were referred for clinically indicated
abdominopelvic CT were prospectively recruited over a 3-
month period. All patients were scanned using a single 64-
slice multi-detector row CT scanner (General Electric
Lightspeed VCT-XTe, GE Healthcare, GE Medical Systems,
Milwaukee, WI, USA). Exclusion criteria included patients
who were less than 18 years of age, those undergoing CT
outside of normal operational hours at our department and
those who did not receive intravenous or oral iodinated con-
trast. The institutional review board waived the requirement
for written informed consent. Patients had their weight and
height measured using a digital device (Seca electronic mea-
suring station Model 763, Seca Medical, Hamburg, Germany)
and their body mass index (BMI) was subsequently recorded.
CT technique
Each CT scan covered an identical anatomic area extending
from the dome of the diaphragm to the pubic symphysis. Each
patient received 1L of positive oral contrast (2%
Gastrograffin, Bracco Diagnostics Inc., Princeton, NJ) and a
100-ml bolus of intravenous contrast (Iohexol, Omnipaque
300, GEHealthcare, Mississauga, ON) delivered at a flow rate
of 2.5 ml/s. Our routine departmental scanning protocol was
used in all cases consisting of a tube voltage of 120 kV, rota-
tion time of 0.8 s, pitch of 0.984:1, z-axis automated tube
current modulation with minimum and maximum tube current
thresholds set at 120 and 300 mA and a noise index of 35.3
HU. Images were acquired at 0.625 mm and subsequently
reconstructed to a slice thickness of 2 mm with 40%
Adaptive Statistical Iterative Reconstruction (ASIR, GE
Healthcare, Milwaukee, WI, USA). Dose length product
(DLP) values were recorded from each CT dose report and
calibration of the CT unit was performed once per week in
accordance with the manufacturer’s instructions. The protocol
was not modified to account for patient BMI apart from em-
ployment of automated tube current modulation.
Quantitative analysis
A single reader (LC) analysed every CT data set using a com-
bination of Bsemi-automated^ threshold-based and Bmanual^
region of interest-based quantitative CT techniques. The fol-
lowing body composition parameters were recorded in each
patient: total volume of abdominopelvic adipose tissue (TAT),
muscle volume (MV), bone volume (BV) and volumes of the
solid organs including the liver, both kidneys and spleen.
Visceral adipose area (VAA) and subcutaneous adipose area
(SAA) were measured on a single slice so that these could be
comparedwith total adipose volume estimates. A second read-
er (FC) repeated each measurement in a random sample of
30% of the patient cohort (n = 71) allowing for calculation
of inter-rater agreement. Parameters requiring threshold-based
segmentation, e.g. total volume of the abdomen/pelvis, total
volume of fat and bone volume, were estimated using a com-
mercial workstation (Advantage Workstation VolumeShare 2,
Version 4.4, GEMedical Systems, Milwaukee, WI) and organ
volumes were calculated using manually drawn regions of
interest with Osirix, an open source medical imaging package
(OsiriX Foundation, Geneva Switzerland).
The total volume of adipose tissue was calculated by auto-
matically removing pixels outside the density range of fat
(−190 HU to -30 HU) [11] within the imaged range of the
abdomen and pelvis. Skeletal muscle volume throughout the
scanned range was calculated in a semi-automated fashion
using the threshold range of -29 HU to +150 HU [12]. Bone
volume was also semi-automatically estimated by performing
the BAutobone extract^ function with subsequent manual
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removal of any high-density oral contrast or non-skeletal cal-
cifications using three-dimensional MIP reconstructions and
the scissor tool. Both visceral and subcutaneous adipose tissue
areas were calculated on a single axial image situated 6 cm
superior to the L4–L5 intervertebral space as recommended
by Demerath et al. [13, 14]. Abdominopelvic organs were
outlined manually on axial CT images using the curved ROI
tool in Osirix, a process that was repeated on adjacent slices
until the organ was completely delineated.
Statistical analysis
Statistical analysis was performed using a commercially avail-
able medical statistical package (PASW version 20, SPSS
Inc., Chicago, IL, USA) (JE, PMcL). Quantitative indices
were compared and correlated using the Student’s t- and
Mann Whitney U-test and Pearson and Spearman’s tests, re-
spectively. Linear regression analysis with DLP as the depen-
dent variable was used to define the strongest body composi-
tion determinant of increased radiation dose. Agreement be-
tween the two quantitative CT readers was compared using the
intra-class correlation coefficient. A difference with a p-value
of <0.05 was considered statistically significant. All data are
presented as mean ± standard deviation unless otherwise stat-
ed. Result variables were grouped by quartile, where appro-
priate. As body composition is known to vary by both sex and
age, a subgroup analysis was performed. The study sample as
divided into four subgroups according to patient sex (male,
female) and patient age (younger, age < 50th percentile;
older, age > 50th percentile) (50th percentile, 59 years) to
evaluate these differences and to compare their effect on the
radiation dose.
Results
A total of 239 patients, 125 females and 114 males with a
mean age of 56.6 ± 17.9 years (range, 19–95 years) and a
mean BMI of 26.5 ± 5.42 kg/m2 (range, 13.9–49.1 kg/m2)
were included for quantitative analysis. The mean DLP
imparted across the study sample was 524 ± 236 mGy.cm
(range, 149–1363 mGy.cm). There was a statistically signifi-
cant correlation between patient BMI and DLP (Pearson’s
correlation; r = 0.797 p < 0.001). DLP was significantly
higher in male patients (580 ± 243 vs. 473 ± 219 mGy.cm,
p < 0.001) and male patients also had significantly higher
BMIs than female patients (28.5 ± 4.8 vs. 24.7 ± 5.3 kg/m2).
All measured body composition parameters correlated pos-
itively with DLP although the correlation was weakest for
spleen volume, only reaching statistical significance at the
0.05 level (Table 1) (Fig. 1a–d). Good agreement was
found when all body composition variables measured by
two observers were compared (intraclass correlation
coefficient of group = 0.877, p < 0.001, n = 71).
Agreement was best for total adipose volume estimation
between observers (intraclass correlation coefficient of
TAT = 0.999, p < 0.001, n = 71).
A multiple linear regression was used to determine which
body composition parameters were the strongest predictors of
radiation dose. Patient dose length product was the dependent
variable and total adipose, muscle, bone, liver, kidney and
spleen volumes were included as independent variables in
the regression model. An R2 value of 0.772 showed that the
variables included in this model accounted for 77% of the
variance of dose length product across our study sample.
Total adipose volume was the strongest predictor of radiation
dose in our group [B(95% CI) = 0.027 (0.024–0.030),
t = 23.068, p < 0.001] and muscle volume also was a signif-
icant predictor of dose length product, albeit to a lesser degree
[B(95% CI) = 0.022 (0.014–0.030), t = 13.516, p < 0.001].
Bone, liver, kidney and spleen volumes did not significantly
predict patient dose length product in this regression model.
In subgroup analysis by sex and age, there was no signifi-
cant difference between groups of different age (p = 0.101).
We found that younger male patients had significantly less
adipose tissue than younger females (p < 0.001) but no other
significant differences were found upon comparison of adi-
pose tissue volumes in other age and sex groups. Muscle vol-
umes were significantly lower in female patients (p < 0.001).
Bone volume was also significantly lower in female compared
with male patients and younger female patients had signifi-
cantly higher bone volumes than older female patients
(p < 0.001). The differences in body composition between
the groups are summarised in Table 2.
To determine which body composition parameter was the
strongest predictor of radiation dose in each individual age-
sex subgroup, the multiple linear regressionmodel was repeat-
ed. Total adipose volume was again found to be the strongest
predictor of dose length product (DLP) in each individual age-
sex subgroup. Interestingly, muscle volume did not signifi-
cantly predict dose length product values in younger female
or younger male patients (p = 0.180 and p = 0.065 respective-
ly) but was predictive of dose length product in older female
and older male patients (Table 3).
BMI is a more readily obtainable parameter than total ad-
ipose tissue volume in clinical practice therefore we sought to
determine the strength of association between patient BMI
and the measured body composition variables in our cohort.
We found that BMI correlated positively and significantly
with all measured body composition parameters, in particular
total adipose tissue (Spearman correlation = 0.798, p < 0.001)
(Table 4). Stepwise linear regression using dose length prod-
uct as the dependent and BMI and total adipose tissue as
independent variables demonstrated however that total adi-
pose tissue [B(95% CI) = 0.022 (0.019–0.025), t = 9.788,
p < 0.001] is more predictive of dose length product than
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Fig. 1 a Scatter plot with linear
regression line outlining the
distribution of total adipose tissue
volume (cm3) and dose length
product (mGy.cm) in our study
sample (n = 239). b Scatter plot
with linear regression line
outlining the distribution of
muscle volume (cm3) and dose
length product (mGy.cm) in our
study sample (n = 239). c Scatter
plot with linear regression line
outlining the distribution of liver
volume (cm3) and dose length
product (mGy.cm) in our study
sample (n = 239). d Scatter plot
with linear regression line
outlining the distribution of
spleen volume (cm3) and dose
length product (mGy.cm) in our
study sample (n = 239)
Table 1 Patient BMI and body
composition variables are
summarised according to quartile
of dose length product
Quartile
(DLP – mGy.cm)
I (<358.6) II (358.6–
431.6)
III (431.6–
640.9)
IV (>640.9) Correlation
with DLP
BMI (kg/m2) 21.3 ± 3 24.2 ± 2 28 ± 3 32 ± 4.8 0.797**
Total adipose tissue
(TAT)
5725 ± 3354 8834 ± 3136 11,554 ± 2883 17,813 ± 4864 0.832**
Muscle volume
(MV)
7368 ± 1378 8033 ± 1585 10,329 ± 2428 11,818 ± 2219 0.660**
Bone volume (BV) 1197 ± 233 1375 ± 281 1602 ± 341 1605 ± 326 0.362**
Liver volume (LV) 1338 ± 309 1392 ± 357 1751 ± 423 1903 ± 495 0.507**
Right kidney volume
(RKV)
127 ± 39 143 ± 36 169 ± 46 175 ± 47 0.393**
Left kidney volume
(LKV)
130 ± 28 147 ± 41 169 ± 41 176 ± 46 0.399**
Spleen volume (SV) 191 ± 250 198 ± 144 259 ± 171 270 ± 205 0.142*
Data presented as mean ± standard deviation. Volumes represented as cm3
Spearman correlation co-efficient; **significant at the 0.001 level, *significant at the 0.05 level
12 Insights Imaging (2018) 9:9–16
BMI [B(95% CI) = 16.045 (11.337–20.752), t = 6.681,
p < 0.001].
Total adipose area measurements (VAA + SAA) obtained
from a single slice (L4–L5 + 6 cm) correlated very closely
with total adipose volume (Spearman’s correlation r = 0.978,
p < 0.001). Stepwise linear regression using these two vari-
ables with dose length product as the dependent yielded al-
most identical results; total adipose volume [B(95% CI) =
0.018 (0.007–0.029), t = 2.746, p = 0.006]; VAA + SAA
[B(95% CI) = 0.018 (0.005–0.031), t = 2.661, p = 0.008].
Discussion
We conducted a descriptive, cross-sectional study in an at-
tempt to identify the body composition predictors of radiation
dose during abdominopelvic CT. Initial analysis confirmed
that each individual variable measured including total
abdominopelvic adipose, muscle, bone and solid organ vol-
umes positively correlated, to varying degrees with dose
length product. As each structure contributes to the overall
x-ray attenuation of the abdomen/pelvis, a positive correlation
for each individual parameter was also not surprising given
that patients with larger adipose, organ, bone and muscle vol-
umes had a larger body habitus in our group. Linear regression
analysis was then used to determine which body composition
parameter was the strongest predictor of radiation dose. We
found that total adipose volume was the strongest predictor
and that muscle volume was also a significant but weaker
predictor of dose length product. Adipose tissue is less dense
and therefore less attenuating than all other body composition
parameters measured in our study but its variability across our
cohort of patients was large. Patients in the fourth quartile of
dose length product (DLP > 620 mGy.cm) had a mean total
adipose volume greater than three times more than patients
who were in the first quartile of dose length product
(DLP < 358 mGy.cm). In comparison, patients in the fourth
quartile of dose length product had ameanmuscle volume that
was approximately 1.5 times more than patients who were in
the first quartile of dose length product. We divided our study
Table 2 Differences in DLP and
body composition variables are
summarised according to
subgroup of patient age and sex
Subgroup Younger female
(<55.6 years)
Older female
(>55.6 years)
Younger male
(<55.6 years)
Older male
(>55.6 years)
DLP (mGy.cm) 492 ± 250 452 ± 180 513 ± 235 620 ± 240
BMI (kg/m2) 25.1 ± 5.8 24.2 ± 4.8 27.4 ± 5 29.1 ± 4.5
Total adipose tissue
(TAT)
10,603 ± 6719 10,861 ± 5200 9696 ± 5069 12,454 ± 5415
Muscle volume
(MV)
8253 ± 2033 7996 ± 2028 10,346 ± 2793 11,092 ± 2313
Bone volume (BV) 1335 ± 214 1138 ± 226 1728 ± 306 1642 ± 273
Liver volume (LV) 1602 ± 453 1313 ± 360 1849 ± 471 1689 ± 438
Right kidney
volume (RKV)
146 ± 43 128 ± 37 174 ± 38 169 ± 49
Left kidney volume
(LKV)
148 ± 39 131 ± 37 176 ± 37 171 ± 45
Spleen volume (SV) 205 ± 229 151 ± 103 283 ± 227 287 ± 185
Data presented as mean ± standard deviation. Volumes represented as cm3
Table 3 Multiple linear regression analysis with dose length product as dependent and body composition variables as the independent variables
summarised according to patient group
Group All patients
(R2 = 0.772)
Younger female
(R2 = 0.861)
Older female
(R2 = 0.684)
Younger male
(R2 = 0.758)
Older male
(R2 = 0.778)
Total adipose tissue (TAT) 0.027 p < 0.001 0.032 p < 0.001 0.017 p < 0.001 −0.029 p < 0.001 9.094 p < 0.001
Muscle volume (MV) 0.022 p < 0.001 0.014 p = 0.180 0.030 p = 0.011 0.017 p = 0.065 3.479 p = 0.001
Bone volume (BV) 0.043 p = 0.145 0.041 p = 0.557 0.091 p = 0.206 −0.031 p = 0.689 0.183 p = 0.855
Liver volume (LV) 0.032 p = 0.157 −0.038 p = 0.402 0.073 p = 0.258 0.050 p = 0.340 1.291 p = 0.201
Right kidney volume (RKV) −0.141 p = 0.712 −0.617 p = 0.396 −0.119 p = 0.851 2.778 p = 0.477 −0.759 p = 0.451
Left kidney volume (LKV) 0.236 p = 0.562 1.197 p = 0.157 −0.097 p = 0.867 −1.614 p = 0.685 0.135 p = 0.893
Spleen volume (SV) −0.017 p = 0.680 −0.011 p = 0.849 −0.399 p = 0.207 0.007 p = 0.951 −0.201 p = 0.842
Data presented are unstandardised co-efficient values (B) of the multiple linear regression model. Significance at the 0.05 level
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sample into four age- and sex-stratified groups and found that
total adipose volume remained the strongest predictor of dose
length product in each subgroup and interestingly that muscle
volumes were predictive of dose length product in older pa-
tients only.
Our findings therefore advance previous knowledge that
has established that patients with an elevated body weight
[6], body mass index [4] or cross-sectional area [5, 7] receive
larger doses of ionising radiation during abdominopelvic CT
with ATCM. Our results indicate that, of the many body tis-
sues that constitute a patient’s BMI or cross-sectional area, it is
a patient’s total abdominal/pelvic adipose tissue that is the
strongest predictor of radiation dose during abdominopelvic
CT.
The challenges that obese patients present to radiology de-
partments, particularly in relation to dose reduction, are now
increasingly recognised [15] because more than 30% of US
adults and almost 20% of European adults have a body mass
index of greater than 30 kg/m2 [16, 17]. Although the
shielding effects of visceral and subcutaneous adipose tissue
result in over 50% less radiation dose to organs deep within
the abdomen in morbidly obese individuals [18], ATCM re-
sults in logarithmic increases in tube current with increasing
patient size [7] and abdominopelvic organ doses in obese pa-
tients are consequentially higher [6]. Furthermore, an effective
dose to the skin and more superficial organs is proportionally
increased with increasing patient size because of the increased
tube current and reduced distance between the patient and the
x-ray source [18].
The necessity to optimise and tailor the ATCM technique
has long been recognised in patients with a large body habitus
[5]. Such efforts to refine dose and noise index parameters
may be of increased importance as new dose reduction tech-
nologies such as iterative reconstruction are being used with
success in patients with a large body habitus [19, 20]. Weight-
based optimisation of ATCM protocols has the advantage of
being easily executed but may not provide an ideal basis to
reduce dose as short obese patients may have the same weight
as tall thin patients [6]. Our results suggest that quantification
of total abdominal adipose tissue could potentially guide radi-
ation dose reduction pathways and facilitate individualised
protocols for optimisation of the ATCM protocol, as it appears
to be the strongest body composition predictor of dose length
product at abdominopelvic CT. This process would be greatly
facilitated if robust automated quantification of total abdomi-
nal adipose tissue could be performed. A possible approach
would be to acquire a single representative abdominal CT
section from which an automated quantification of total ab-
dominal adipose tissue could be performed. Another possibil-
ity in the case of follow-up or repeat CT studies would be to
analyse previous CT scans, to allow quantification of total
abdominal adipose tissue and allow protocols to be modelled
based on abdominal fat distribution, thereby optimising the
dose while preserving image quality. It should be noted that
measurement of visceral adipose tissue appears reproducible
between various dose reduction and image reconstruction
strategies [21].
We concede that our study is entirely descriptive with stud-
ies from a single CTscanner and that the practical relevance of
our results will require further assessment and research. To
limit possible confounding factors we used a single scanner
with a standard imaging technique and we acknowledge that
newer dose reduction techniques and scanner technologies
(such as automated tube voltage selection) may impart differ-
ing doses to the various tissue types while reducing the overall
dose [22]. We acknowledge that the volume of intravenous
and oral contrast administered affects automated tube current
modulation [6, 23] and our cohort received standard IV and
oral contrast, not weight-adapted doses of contrast. Oral con-
trast distribution was heterogeneous throughout the
Table 4 Radiation exposure and
body composition variables are
summarised according to quartile
of patient body mass index
Quartile
(BMI – kg/m2)
I (<22.7) II (22.7–26.2) III (26.2–29.3) IV (>29.3) Correlation
with BMI
DLP (mGy.cm) 340 ± 68 420 ± 129 541 ± 158 804 ± 230 0.797**
Total adipose tissue
(TAT)
6241 ± 3087 8863 ± 4083 12,068 ± 3374 17,316 ± 5185 0.798**
Muscle volume
(MV)
7212 ± 1126 8828 ± 2277 10,044 ± 2664 11,644 ± 2006 0.624**
Bone volume (BV) 1196 ± 243 1417 ± 263 1585 ± 387 1600 ± 304 0.423**
Liver volume (LV) 1306 ± 374 1546 ± 382 1641 ± 422 1910 ± 480 0.524**
Right kidney volume
(RKV)
131 ± 40 144 ± 30 160 ± 56 180 ± 43 0.394**
Left kidney volume
(LKV)
136 ± 36 146 ± 27 162 ± 52 181 ± 44 0.398**
Spleen volume (SV) 187 ± 254 206 ± 133 266 ± 176 264 ± 201 0.132*
Data presented as mean ± standard deviation. Volumes represented as cm3
Spearman correlation co-efficient; **significant at the 0.001 level, *significant at the 0.05 level
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gastrointestinal tract, as completely homogenous bowel
opacification is difficult to attain and may impart a dose length
product increase that would be greater than a single small
organ such as a single kidney or the spleen.
A practical limitation of our study is that quantitatively
obtaining a patient’s total adipose volume represents an addi-
tional workflow challenge in the day-to-day practice of CT.
CT scanners could also benefit practically from including the
patient’s height in addition to their weight to optimise the
radiation dose, as short obese patients may have the same
weight as tall thin patients [6].
We did not formally record the time taken to perform the
quantitative measurements in this study but manual delinea-
tion of organs and the process of bone and muscle segmenta-
tion were subjectively laborious and time consuming, taking
at least 20 min per patient. In contrast the process of
Hounsfield unit thresholding to generate total adipose mea-
surements across each series was subjectively quick (~30 s)
and interobserver agreement was highest for adipose assess-
ment in our study (intraclass correlation of TAT = 0.999,
p < 0.001, n = 71), suggesting that total adipose estimation
from a patient’s previous CTscan would be more feasible than
other estimates in clinical practice. However, obtaining a total
adipose volume would also be impossible in patients who are
undergoing their first CT scan. A consideration in this situa-
tion would be to analyse adipose area on a single CT image
taken at the time of the topogram. Many studies investigating
body composition using cross-sectional images have used this
approach particularly when estimating visceral and subcuta-
neous adipose quantities with good success [13, 14]. The ex-
cess radiation dose imparted during the acquisition of this
single slice has been estimated to be in the range of 0.015–
0.019 mSv/37–54 kg of patient weight, which compares
favourably with the typical dose imparted during the acquisi-
tion of a CT topogram. In our patient group total adipose area
measurements (VAA+ SAA) obtained from a single slice (L4-
L5 + 6 cm) correlated very well with total adipose volume
(Spearman’s correlation r = 0.978, p < 0.001), which may be
of value in the practical application of our findings.
In conclusion, the abdomen and pelvis house many organs
and tissues of varying volume and density but the volume of
adipose tissue was the strongest predictor of radiation dose.
This finding is fortunate however as during the interpretation
of CT images, intra-abdominal fat, when present in sufficient
volume, can separate bowel loops from adjacent intra- and
retroperitoneal structures effectively providing Binternal^ con-
trast that can help the interpreting radiologist to more accu-
rately localise and identify pathology. As a consequence, nu-
merous studies suggest that the decision to administer or with-
hold oral contrast agents should be based on the patient’s
adiposity [24–26]. The authors raise the possibility that more
aggressive dose reduction could also be employed on the basis
of adipose tissue volumes that could be derived from previous
CT scans or from single-slice analysis in those without previ-
ous CTs. Further research is required to evaluate the practical
relevance of these parameters and to better define how it may
help to optimise the CT technique and reduce the radiation
dose.
Compliance with ethical standards The study was approved by the
institutional ethics research committee. The institutional review board
waived the requirement for written informed consent, as the patient’s
treatment was not altered by the study protocol.
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